The kinetics and extent of engraftment of chronic myelogenous leukemia cells in non-obese diabetic/severe combined immunodeficiency mice reflect the phase of the donor's disease: An in vivo model of chronic myelogenous leukemia biology

Blood

Volumn 92, Issue 4, 1998, Pages 1390-1396

  Dazzi, Francesco ^a   Capelli, Debora ^b   Hasserjian, Robert ^b   Cotter, Finbarr ^b   Corbo, Margherita ^b   Poletti, Alessandro ^b   Chinswangwatanakul, Wimol ^b   Goldman, John M ^b   Gordon, Myrtle Y ^b  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COUNT; CELL INFILTRATION; CELL KINETICS; CELL PROLIFERATION; CHRONIC MYELOID LEUKEMIA; COMBINED IMMUNODEFICIENCY; DISEASE COURSE; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; TISSUE SPECIFICITY;

EID: 0032529306     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.4.1390.416k09_1390_1396     Document Type: Article

References (23)

1. Goldman JM, Shiota F, Th'ng KH, Orchard KH: Circulating granulocytic and erythroid progenitor cells in chronic granulocytic leukaemia. Br J Haematol 46:7, 1980
2. Marley SB, Lewis JL, Goldman JM, Gordon MY: Abnormal kinetics of colony formation by erythroid burst-forming units in chronic myeloid leukemia. Br J Haematol 93:878, 1996
3. Udomsakdi C, Eaves CJ, Swolin B, Reid DS, Barnett M, Eaves AC: Rapid decline in chronic myeloid leukemia cells in long-term culture due to a defect at the stem cell level. Proc Natl Acad Sci USA 89:6192, 1992
4. Gordon MY, Goldman JM: Cellular and molecular mechanisms in chronic myeloid leukaemia: Biology and treatment. Br J Haematol 95:10, 1996
5. Gordon MY, Blackett NM: Routes to repopulation: A unification of the stochastic model and separation of stem cell subpopulations. Leukemia 8:1068, 1994
6. Bedi A, Zenbauer BA, Barber JP, Sharkis SJ, Jones RJ: Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia. Blood 83:2038, 1994
7. Uckun FM: Severe combined immunodeficient mouse models of human leukemia. Blood 88:1135, 1996
8. Greiner DL, Schultz LD, Yates J, Appel MC, Pedrizet G, Hesselton R, Schweitzer I, Beamer WG, Shultz KL, Pelsue SC, Leif JH, Rajan TV: Improved engraftment of human spleen cells in NOD/LtSz-scid/scid mice as compared with C.B-17-scid/scid mice. Am J Pathol 146:888, 1995
9. Larochelle A, Vormoor J, Hanenberg H, Wang JCY, Bhatia M, Lapidot T, Moritz T, Murdoch B, Li Xiao X, Kato I, Williams DA, Dick JE: Identification of primitive human hematopoietic cells capable of regulating NOD/SCID mouse bone marrow: Implications for gene therapy. Nat Med 2:1329, 1996
10. Wang JCY, Doedens M, Dick JE: Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulating cell assay. Blood 89:3919, 1997
11. Bonnet D, Dick JE: Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hemopoietic cell. Nat Med 3:730, 1997
12. Yano S, Sone S: Novel metastasis model of human lung cancer cells representing different histological types in SCID mice depleted of NK cells. Can To Kagaku Ryoho 24:489, 1997
13. Honma Y, Matsuo Y, Hayashi Y, Omura S: Treatment of Philadelphia-chromosome-positive human leukemia in SCID mouse model with herbimycin A, bcr/abl tyrosine kinase activity inhibitor. Int J Cancer 60:685, 1995
14. Skorski T, Nieborowska-Skorska M, Wlodarski P, Zon G, Iozzo RV, Calabretta B: Antisense oligonucleotide combination therapy of primary chronic myelogenous leukemia blast crisis in SCID mice. Blood 88:1005, 1996
15. Druker BJ, Tamura S, Buchdunger E, Ohno S, Segal GM, Fanning S, Zimmermann J, Lydon NB: Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of BCR-ABL positive cells. Nat Med 2:561, 1996
16. Yurasov S, Kollman TR, Kirn A, Raker CA, Hachamocitch M, Wong-Staal F, Goldstein H: Severe combined immunodeficiency mice engrafted with human T cells, B cells, and myeloid cells after transplantation with human fetal bone marrow or liver cells and implanted with human fetal thymus: A model for studying human gene therapy. Blood 89:1800, 1997
17. Sirard C, Lapidot T, Vormoor J, Cashman JD, Doedens M, Murdoch B, Jamal N, Messner H, Addey L, Minden M, Laraya P, Keating A, Eaves A, Lansdorp PM, Eaves CJ, Dick JE: Normal and leukemic SCID-repopulating cells (SRC) coexist in the bone marrow and peripheral blood from CML patients in chronic phase, whereas leukemic SRC are detected in blast crisis. Blood 87:1539, 1996
18. Pegoraro L, Matera L, Ritz J, Levis A, Palumbo A, Biagini G: Establishment of a Ph-positive human cells line (BV173). J Natl Cancer Inst 70:447, 1983
19. Grand FH, Marley SB, Chase A, Titley I, Healy L, Spencer A, Reiter A, Goldman JM, Gordon MY: BCR/ABL-negative progenitors are enriched in the adherent fraction of CD34+ cells circulating in the blood of chronic phase myeloid leukemia patients. Leukemia 11:1486, 1997
20. Sawyers CL, Gishizky ML, Qaun S, Golde DW, Witte ON: Propagation of human blastic myeloid leukemias in the SCID mouse. Blood 79:2089, 1992
21. Chase A, Grand F, Zhang JG, Blackett N, Goldman JM, Gordon MY: Factors influencing the false positive and negative rates of BCR-ABL fluorescence in situ hybridization. Genes Chromosom Cancer 18:246, 1996
22. Kirk JA, Reems JA, Roecklain BA, van Deranter BR, Bryant EM, Radich J, Edmonds S, Lee A, Torok-Storb B: Benign marrow progenitors are enriched in the CD34+/HLA-DRlo population but not in the CD34+/CD381o population of chronic myeloid leukemia: An analysis using interphase fluorescence hybridization. Blood 86:737, 1995
23. Verfaillie CM, Bhatia R, Miller W, Mortari F, Roy V, Burger S, McCulloch J, Stieglbauer K, Dewald G, Heimfeld S, Miller JS, McGlave PB: BCR/ABL-negative primitive progenitors suitable for transplantation can be selected from the marrow of most early chronic phase but not accelerated phase chronic myeloid leukemia. Blood 87:4770, 1996